from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3117/cysA3

LFCtreatmentdescriptionclass of inhibitor

-0.259

Amikacinug/mL Amikacintranslation

0.018

Cap5-10ug/mL Capreomycintranslation

0.958

Rox10-50 ug/mL Roxithromycintranslation

1.588

SM2-5 ug/mL Streptomycintranslation

0.096

Tet5-10 ug/mL Tetracyclinetranslation

-1.033

Rif0.2-5ug/mL Rifampicintranscription

-0.257

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.747

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.224

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.816

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.364

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.540

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.833

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.945

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.596

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.790

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.540

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.426

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.977

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.901

Nigericin50 uM Nigericinrespiration

-1.336

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.152

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.666

menadione6-10 ug/mL Menadionerespiration

-0.297

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.448

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.733

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.104

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.035

NRP_1Non-replicating persistence stage 1dosRassociated

0.446

Amp0.2mg/mL AmpicillincellWall

0.405

Cephalexin20-100 ug/mL CephalexincellWall

0.971

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.090

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.173

EMB10-20 ug/mL EthambutolcellWall

0.797

Eta12-40 ug/mL EthionamidecellWall

0.904

INH0.2-0.4 ug/mL IsoniazidcellWall

0.383

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.818

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.363

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.047

BZA0.12 mg/mL BenzamidearomaticAmides

-1.480

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.234

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.287

H2O24 mM hydrogen peroxideDNAdamaging

-0.013

Levo10 ug/mL LevofloxacinDNAdamaging

0.478

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.674

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.106

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.559

UVUV-irradiationDNAdamaging

0.602

ARP41-4 ug/mL Antitubercular compound ARP4?

0.500

Antimycin12.5-50 ug/mL Antimycin A?

0.008

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.201

PA_110-50 ug/mL Antitubercular compound PA-1?

0.366

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.702

PA8240.2-2 ug/mL PA-824?

0.838

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.103

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.726

Verapamil50 uM Verapamil?

-0.922

mercaptoethanol2 mM 2-Mercaptoethanol?

0.327

methoxatin10-20 ug/mL Methoxatin?